Xinrui Chen
Chinese Academy of Medical Sciences & Peking Union Medical College
ORCID: 0000-0001-8780-4076Also affiliated with China Academy of Engineering Physics, Shantou University, Second Affiliated Hospital of Guangzhou Medical University, Cancer Hospital of Shantou University Medical College, First Affiliated Hospital of Guangzhou Medical University, Affiliated Hospital of North Sichuan Medical College, The Affiliated Yongchuan Hospital of Chongqing Medical University, Guangzhou Psychiatric Hospital, Institute of Applied Physics and Computational Mathematics, Fu Wai Hospital, Guangdong 999 Brain Hospital, Chongqing Medical University, Guangzhou Medical University
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 1 paper. Top paper: “Efficacy and safety of PD‐1 monoclonal antibody plus rituximab in relapsed/refractory diffuse large B cell lymphoma patients”.
Xiaohui He, Xinrui Chen, Zucheng Xie, Jianliang Yang, Sheng Yang +6 more